I was too sheepish to have a conversation with them about it, so I left the pen in my toiletry bag and didnt throw it in the trash until I got home
Meanwhile, it also wants Lilly to conduct prospective, registry-based studies looking at safety in children and adolescents, pregnancy, and medullary thyroid cancer, as simply monitoring spontaneous postmarketing adverse events is not considered adequate for these purposes
Is switching from Ozempic/Wegovy to Mounjaro/Zepbound the same thing
The implication is clear: monthly attrition is a critical metric, and obesity GLP-1s face a steeper slope due to a combination of clinical ambiguity, payer friction, and patient psychology
The guide on four weeks on semaglutide with no weight loss specifically addresses early non-response, while tirzepatide not working anymore addresses the scenario where effects diminish over time